News & Announcements

New technology developed by U of M researchers, supported in part by MnDRIVE, can detect oak wilt fungus earlier, faster, and at a lower cost than prior methods. 

U of M scientists played a crucial role in helping a first-of-its-kind treatment for several rare genetic diseases reach clinical trials.

A U of M startup has garnered seed investments to develop its faster, more accurate disease detection technology.

A recent Association of University Technology Managers survey ranked the U of M second among Big Ten schools when it comes to licensing revenue.

University of Minnesota scientists contributed to the preclinical work that led to the first-ever clinical trial of a gene therapy that edit the DNA from inside the body. 

Innovation fellows from the U of M's Medical Devices Center have developed an app that may cure snoring.

Warren Watson, a medical device industry consultant and former vice president of Medtronic, highlights how U research is helping shape Minnesota's business environment. 

U of M startup CoreBiome has partnered with a clinical-stage biotech company to harness the health potential of gut microbes.

The U of M's Jay Schrankler, associate vice president of technology commercialization and new ventures, discusses the rise in industry-funded research and technology commercialization. 

U researchers have earned a patent for a new kind of injectable antidote for cyanide poisoning.